Yes, AIT’s manufacturing facilities undergo inspections by regulatory authorities to ensure compliance with industry standards and regulations. These inspections may include assessments of the facility’s adherence to Good Manufacturing Practices (GMP), quality control measures, documentation practices, and overall compliance with regulatory requirements.
AIT Pharmaceuticals Project takes proactive measures to prepare for and successfully undergo these inspections. This may involve implementing robust quality management systems, maintaining thorough documentation of manufacturing processes, conducting internal audits to identify and address potential compliance issues, and providing ongoing staff training on regulatory requirements.
Upon successful completion of inspections and approval by regulatory authorities, AIT’s manufacturing facilities are authorized to produce pharmaceutical products for distribution in their respective markets. This approval demonstrates AIT’s commitment to maintaining high standards of quality and compliance in its manufacturing operations.
